From 380S particles of Berne virus (proposed family Toroviridae) one species of polyadenylated RNA was isolated. Using agarose gel electrophoresis its length was estimated as 20 kb or greater. When assayed under hypertonic transfection conditions genomic RNA was found to be infectious; RNase treatment destroyed the infectivity. The positive polarity of the molecule was confirmed by filter spot hybridization using cDNA prepared against poly(A)-selected RNA from infected cells. In embryonic mule skin cells infected with Berne virus the presence of five virus-specific, polyadenylated RNA species of 7.5, 2.1, 1.4, 0.8 and at least 20 kb was demonstrated. In vitro translation of the 7.5, 2.1 and 0-8 kb RNAs followed by immunoprecipitation showed that they encode a 151K product (possibly the precursor to the peplomer proteins), the envelope protein and the nucleocapsid protein, respectively.
INTRODUCTION
Berne virus (BEV) of horses is a representative of a recently defined group of vertebrate RNA viruses, for which the family status and the name Toroviridae have been proposed Horzinek et al., 1987) ; antigenically related toroviruses have been demonstrated in cattle (Woode et al., 1985) and humans (Beards et al., 1984) . The present state of knowledge regarding the toroviruses has been reviewed recently (Weiss & Horzinek, 1987; Horzinek et al., 1987) . The equine isolate BEV is the best studied member of the proposed family, since it is the only torovirus so far that can be propagated in cultured cells.
Berne virus possesses a peplomer (P)-bearing envelope surrounding a tubular nucleocapsid with helical symmetry. The virion contains four polypeptides. The major protein is a phosphorylated 20K polypeptide, which has been identified as ttie nucleocapsid protein (N) (Horzinek et al., 1985) . A 22K non-glycosylated envelope protein (E) and a 37K phosphorylated matrix protein (M) are associated with the viral membrane (Horzinek et al., 1985) . The BEV P consists of N-glycosylated polypeptides with MrS in the range 75K to 100K .
Earlier experiments (Weiss et al., 1983) have indicated that BEV possesses an RNA genome, since its growth is not inhibited by iododeoxyuridine. Viral replication is inhibited by actinomycin D (AMD), ~-amanitin and u.v. pre-irradiation of the cells suggesting that the expression of a cellular gene is essential for BEV multiplication .
In this paper some properties of the genome of BEV are reported and the presence of five BEV-specific poly(A)-containing RNAs in infected cells is described. buffered saline (PBS) containing 50 mg/l DEAE-dextran and infected with BEV (strain P138/72). In most experiments the inoculum was from a seed lot pretreated at an earlier passage level with 2-phenyl ethanol for inactivation of contaminating mycoplasma (Staal & Rowe, 1974) . After 1 h adsorption the inoculum was removed and DMEM containing 3% FCS and antibiotics was added. Supernatants were harvested at 24 to 30 h postinfection (p.i.), the beginning of c.p.e.
Breda II virus purified from faecal material by pelleting and isopycnic centrifugation was kindly provided by G. Woode (Texas A & M University, College Station, Tx., U.S.A.). Propagation and purification of mouse hepatitis virus (MHV), a coronavirus, has been described previously .
Titration of infectivity, virus neutralization and ELISA methods have been described in detail (Weiss et al., 1983) .
Virus purification and gradient analysis. Supernatants of infected cultures were clarified by low-speed centrifugation. Ammonium sulphate precipitation (50% saturation) was allowed to proceed for 1 to 2 h at 4 °C. After low-speed centrifugation, the pellet was resuspended in TES buffer (10 mM-Tris-HC1 pH 7.4, 1 mM-EDTA, 150 mM-NaC1), clarified again and the remaining ammonium sulphate was removed by gel filtration (Sephadex PD-10 column; Pharmacia). Linear sucrose gradients were prepared and centrifuged under equilibrium (Weiss et al., 1983) or rate zon~,l (Horzinek et al., 1985) conditions as reported previously. Preformed isokinetic sucrose gradients were used for the calculation of sedimentation coefficients as described by Van der Zeijst & Bloemers (1976) ; the tubes were centrifuged in SW27 or SW28.1 rotors of a Beckman L65 ultracentrifuge equipped with an ~02/dt integrator. After fractionation, the infectivity was determined for each fraction (Weiss et al., 1983) . Metabolically labelled BEV was located by liquid scintillation counting.
Isotope labelling and isolation ofgenomic RNA. EMS cell cultures were infected as described, and at 4 h p.i. the medium was replaced by phosphate-free DMEM supplemented with 2% dialysed FCS. One hour later, carrierfree [32p]orthophosphate was added, to result in a final isotope concentration of 500 ~tCi/ml. For uridine labelling, infection was performed as described above and 25 to 50 ttCi/ml of [3H]uridine was added 4 h p.i. ; material was harvested 24 h p.i. All isotope preparations were purchased from Amersham. To isolate the viral genome, gradient-purified virus was treated with 0-4% SDS, 400 ixg/ml proteinase K and 500 ~tg/ml tRNA for 30 rain at 37 °C followed by 30 min at 56 °C. The RNA was extracted with phenol/chloroform and ethanol-precipitated.
RNA transfection assay. The method has been described before . In short, confluent monolayers of EMS cells in 35 mm Petri dishes were rinsed with PBS and hypertonic buffer 1 (HB1 ; 600 mM-NaC1 in 10 mM-Tris-HCl pH 7.5, containing 20 ~tg/ml of polyvinyl sulphate), and then incubated for 5 rain with hypertonic buffer 2 (HB2; as above, but containing 1.1 M-NaC1). The RNA preparation in 200 ktl of HB2 was pipetted onto the monolayers and incubated for 15 min; the inoculum was then removed, cells were washed once with HB1 and DMEM with 10% FCS was added. All manipulations were done at room temperature. The c.p.e. was read after 3 days of incubation. The virus specificity and single-strandedness of the transfecting RNA was demonstrated by treatment of the extracts with bovine pancreatic RNase A (5 mg/ml, in 140 rnM-NaC1, 14 mMsodium citrate and 10 mM-MgClz) for 30 min at 30 °C.
Poly(A) selection and agarose gel electrophoresis. Oligo(dT)-cellulose chromatography was performed as described by Maniatis et al. (1982) . RNA was analysed in 1~o agarose gels after denaturation with glyoxal/dimethylsulphoxide (Spaan et al., 198 I) or formamide/formaldehyde (Meinkoth & Wahl, 1984) . Gels were fixed in methanol, soaked in En3Hance (New England Nuclear), if necessary, and dried. Fluorography was performed as described by Laskey (1980) .
Filter spot hybridization. Poly(A)-selected [poly(A) ÷] RNA from infected and uninfected cells was used as template for the synthesis of labelled cDNA as described before (van Berlo et al., 1986) . RNA was spotted onto nitrocellulose filters and RNA :DNA hybridization was performed essentially as described by van Berlo et al. (1986) at 52 °C.
3Hlabelling and extraction ofintracellular RNAs. EMS cells grown in 35 mm tissue culture dishes were infected at a high m.o.i. (5 to 10) as described above. At 1 h p.i. the inoculum was removed and DMEM containing 3% FCS and 50 ttCi/rnl [3H]uridine was added. The cells were lysed at 13 h p.i. and RNA was extracted as described by Spaan et al. (1981) . When AMD was used to inhibit host cellular RNA synthesis, the drug was added late after infection (8 h p.i.) at a concentration of 1 ~tg/ml; 1 h later, the cells were labelled by adding 50 IxCi/ml [3H]uridine, and at 13 h p.i. the RNA was extracted.
Measurement of [3H] uridine incorporation into RNA. Samples were spotted on Whatman 3MM filter paper and TCA-precipitated. Radioactivity was measured by liquid scintillation counting. After electrophoresis, RNA bands were excised from the dried agarose gels, soaked in scintillation fluid and counted.
Isolation of mRNAs from infected cells. At 13 h p.i. total RNA was isolated from 2.7 x 108 BEV-infected (m.o.i. approx. 7) EMS cells grown in plastic roller bottles (Costar; surface area 900 cm2). Cell lysis and RNA extraction were performed as described by Spaan et al. (1981) and 300 Ixg poly(A) + RNA was recovered after oligo(dT)-cellulose column chromatography and ethanol precipitation. Of this material 200 p.g was mixed with 3H-labeUed poly(A) ÷ RNA from 2 x 107 BEV-infected EMS cells; this mixture was separated on a 5 to 29% (w/w) isokinetic sucrose gradient by ultracentrifugation for 4 h at 41000 r.p.m. (o92t = 2.7 x 101 ~ rad2/s) in a Beckman SW41 rotor (Van der Zeijst & Bloemers, 1976) . Sucrose solutions and RNA samples were prepared as described by Jacobs et al. (1986) . The RNA in the resulting 36 fractions (330 ~tl each) was recovered by ethanol precipitation and used for analysis in agarose gels and in vitro translation.
In vitro translation of mRNAs. One-third of the precipitate from each gradient fraction (1 ~tl) or 5 ktg total polyadenylated RNA were translated by adding 10 p.l of a rabbit reticulocyte lysate (N. 90; Amersham) and 1 I11 of [35S]methionine (15 I~Ci)~ After 60 min of incubation at 30 °C the reaction mixtures were cooled on ice, diluted twofold in TES buffer containing 4 mM-PMSF and analysed by SDS-PAGE, either directly or after immunoprecipitation (see below).
Radioactive labelling of virion proteins. Virus was labelled with [3sS]methionine by incubating infected cell cultures from 9 to 12 h p.i. in methionine-deficient DMEM, supplemented with 3 ~ dialysed FCS and 50 ~tCi/ml [3sS]methionine. Virions were isolated from the cell culture medium by ultracentrifugation at 200000 g at 4 °C for 2 h. Pellets from infected and mock-infected culture supernatants were dissolved in electrophoresis sample buffer (10mM-Tris-HCl pH8-0, 1 mM-EDTA, 10% glycerol, 2~ w/v SDS, 5% 2-mercaptoethanol, 0.001~ w/v bromophenol blue) and used as viral protein markers in SDS-PAGE.
Immune sera and monoclonal antibodies. A field serum from a horse with BEV neutralizing antibodies was used in radioimmunoprecipitations. In addition, monoclonal antibodies (MAbs) directed against the BEV N and P proteins (MAbs 1FI and 6B10, respectively; B. Kaeffer et al., unpublished data) were used.
Radioimmunoprecipitation (RIP) and SDS-PAGE. Viral proteins were precipitated by adding 7.5 I11 aliquots of the anti-BEV horse serum or 5 ~tl volumes of anti-BEV MAb ascites fluid to 10 p.1 portions of diluted translation mixtures. The mixtures were diluted in TES buffer containing 2 mM-PMSF to result in final volumes of 75 ~1. After 15 min of incubation at 37 °C, 50 Ixl of a 10% (w/v) suspension of formalin-treated Staphylococcus aureus cells in RIP buffer (10 mM-Tris-HCl pH 7-4, 1 ~ w/v sodium deoxycholate, 1% NP40 and 150 mM-NaCI) was added and incubation was continued for another 15 min at 37 °C. The S. aureus cells with the adsorbed immune complexes were centrifuged down, washed three times in 0.5 ml RIP buffer and the final pellet was dissolved in 35 p.l of electrophoresis sample buffer. After removal of the S. aureus by centrifugation, samples were analysed by SDS-PAGE on gels ranging from 7-5 to 20% in polyacrylamide concentration. Fluorography was performed as described by Laskey (1980) .
RESULTS

Purification of virions and genome isolation
In view of the heterogeneity in density of BEV-specific structures encountered in the supernatants of infected cells (Horzinek et al., 1985) , sedimentation experiments were performed in sucrose gradients. Berne virus labelled with [32p]orthophosphate or [3H]uridine was partly purified from infectious culture media and analysed in isokinetic sucrose gradients. Peaks of TCA-precipitable radioactivity were observed at positions of 380S and 50S. No labelled sedimentable material was seen in mock-infected EMS culture supernatants (data not shown). The bulk of viral infectivity and ELISA activity sedimented at a velocity corresponding to 380S (data not shown). When run in an equilibrium centrifugation, the 380S particles banded at virion density (1.16 to 1.17 g/ml; Weiss et al., 1983) .
Further experiments were focused on the 380S material. The RNA from this peak was extracted and analysed by agarose gel electrophoresis. A single RNA species was detected in the material containing the 380S particles (Fig. 1 a) .
Infectivity and polarity of the BEV genome
A transfection assay using purified genomic RNA can be used to discriminate between positive-and negative-stranded RNA viruses. Extraction using the proteinase K/SDS/phenol method was performed on a virus preparation containing about 101° TCID of BEV. Dilutions of the RNA were transfected into EMS cell monolayers using hypertonic pretreatment. Undiluted material was digested with RNase A before transfection. After incubation of the cultures for 3 days, complete c.p.e, had developed in the preparations diluted fivefold and 25-fold, with c.p.e. beginning in the 1:125 dilution. Cytopathic changes were absent in the RNase-treated preparation. Identification of the virus released fl'om cells transfected with the I :125 dilution of BEV RNA was done using a neutralization assay. A neutralization index of 4.2 was found using a 1:50 dilution of a horse serum that had been selected for its antibody content.
The BEV genome was found to be polyadenylated by using oligo(dT)-cellulose column chromatography. The RNA was extracted from [3H]uridine-labelled BEV and the column flowthrough and eluate were analysed by agarose gel electrophoresis, using M H V strain A59 intracellular R N A s as Mr markers. As depicted in Fig. 1 (b) , genomic R N A of BEV was bound to the column. The BEV genome comigrated with M H V intracellular R N A 1 ; since large R N A species are not resolved in the top (non-linear) portion of agarose gels (Lehrach et al., 1977) , we refrain from giving an exact figure for the genome length but estimate it to be 20 kb or longer.
To compare genome and messenger R N A polarity, filter hybridization experiments were performed using 32p-labelled c D N A probes prepared against poly(A) ÷ R N A from BEVinfected cells. Hybridization occurred with R N A extracted from purified BEV (Fig. 2, A3 , B3), and with poly(A) ÷ R N A from infected cells (undiluted, 10 -~, 10 -2) serving as positive controls (Fig. 2, A1 , B1, C1). No reaction was encountered with poly(A) ÷ R N A from mock-infected cells diluted 10 -1 or more (Fig. 2, B2, C2) ; a faint signal occurred with the undiluted material (Fig. 2,  A2) . A distinct spot was detected when R N A of an antigenically related torovirus (Breda II; Woode et al., 1982) was included (Fig. 2, B4) .
Identification of Berne virus-induced mRNAs
In order to identify virus-specific intracellular RNA, BEV-infected EMS cells were labelled with species that were absent from uninfected cells (Fig. 3a) . To demonstrate the viral origin of these RNA species, we used AMD, an inhibitor of DNA-dependent RNA transcription. Although this drug is known to interfere with BEV replication, its influence decreases when added late after infection . We labelled cells with [3H]uridine from 9 to 13 h p.i. after * Calculated from agarose gels, using eukaryotic rRNAs and MHV-specific mRNAs as markers. t Intracellular RNA was labelled with [3H]uridine from 9 to 13 h p.i. in the presence of AMD. RNA bands were excised from agarose gels and counted. Relative molarities were calculated using the Mr data from this table.
~; As estimated from the sedimentation behaviour of poly(A) + selected RNAs in a 5 to 29% (w/w) isokinetic sucrose gradient (Van der Zeijst & Bloemers, 1976) . addition of I ~tg/ml A M D at 8 h p.i. It can be concluded from Fig. 3 (a) (Table 1) . To quantify the relative amounts of R N A synthesized between 9 and 13 h p.i. in the presence of AMD, individual bands were excised from the gel and counted; the resulting molarities are shown in Table 1 . The five virus-specific R N A s were further characterized by oligo(dT)-cellulose column chromatography of 3H-labelled total R N A from infected cells (which had not been treated with AMD). All five RNAs were found to bind to the column (Fig. 3 b) .
Isolation and fractionation of virus-specific intracellular RNAs
To purify BEV-specific intracellular R N A s for in vitro translation, R N A was isolated from BEV-infected EMS cells by phenol extraction and ethanol precipitation. Poly(A) + R N A was prepared by oligo(dT)-cellulose column chromatography. Sixteen percent of the total R N A was bound to the column, while only 5 % of the material from mock-infected cells was retained.
A mixture of 3H-labelled and unlabelled poly(A) ÷ material from infected cells was layered on top of an isokinetic sucrose gradient and the R N A was fractionated after ultracentrifugation. The R N A content of each fraction was analysed by agarose gel electrophoresis using 3H-labelled R N A from infected, AMD-treated cells as markers. Peak amounts of the BEV-specific R N A s 1 to 5 were recovered from fractions 4, 20, 27, 29 and 31, respectively (Fig. 4) . The sedimentation coefficients calculated for these R N A species are listed in Table 1 .
Translation of individual mRNAs of Berne virus
Samples enriched for individual BEV R N A s were used for in vitro translation to establish the coding assignments for the five viral R N A species. N o protein product could be detected after translation of the R N A from fraction 4 (containing the largest quantity of R N A 1). When R N A 2-containing fractions were translated, a 151K polypeptide product appeared (Fig. 5 a, lane 1) . Its highest level of synthesis coincided with the maximum amount of R N A 2 (fraction 20). However, this protein was recognized only poorly in immunoprecipitation using a BEV-specific horse serum (Fig. 5 a, lane 2) . The results were even less conclusive when the precipitation was performed using a neutralizing MAb (6BI0), which recognizes the BEV P proteins and their intracellular precursor (data not shown).
Due to the small differences in size between BEV RNAs 3, 4 and 5, considerable crosscontamination remained after separation in a sucrose gradient (Fig. 4, lanes 4, 5 and 6 ). Nevertheless, peaks of translation were observed for the 21K product in fraction 27 (corresponding to RNA 3) and for the 19K, 18K and 16K polypeptides in fraction 31 (containing the largest amount of RNA 5). No protein product(s) could be assigned to fraction 29 (the peak of RNA 4). The 21K and 19K products co-electrophoresed with the two most prevalent viral proteins in both virions and BEV-infected cells, the unglycosylated envelope protein and the BEV nucleocapsid protein, respectively (Fig. 5b, lanes 1 to 6) . In immunoprecipitations, the 21K, 19K, 18K and 16K translation products were recognized by the horse serum (Fig. 5b, lanes 1 to 3) . In addition, the 19K, 18K and 16K polypeptides could be precipitated using the IF1 MAb, directed against the BEV nucleocapsid protein (Fig. 5b,  lane 4) .
DISCUSSION
In previous studies we have shown that virus-specific material released from EMS cells after infection with BEV consists of two major density classes: the infectious virion (I-16 to 1.17 g/ml in sucrose; Weiss et al., 1983 ) and peaks of virus-specific activities with densities of 1.11 g/ml and lower (Horzinek et al., 1985) . In the present study sedimentation heterogeneity was observed, which resulted in the identification of virus-specific 380S and 50S particles. The 380S material contains the bulk of infectious virions. The 50S material, when centrifuged in an equilibrium gradient, banded at a density of 1.11 g/ml. Purification of the 380S particles was essential for the characterization of the BEV genomic RNA.
A positive polarity for the torovirus genome was established with the aid of transfection and filter hybridization experiments. Polyadenylation was also found, which is another indication of positive polarity. Lack of polyadenylation, however, does not exclude it; flavi-and pestiviruses possess genomes of messenger polarity without poly(A) tracts (Schlesinger, 1980; Renard et al., 1985) .
In this paper the presence of at least five virus-specific RNA species in BEV-infected cells is demonstrated. The fact that these RNAs are polyadenylated suggests that they can function as mRNAs. Identification of the translation products of RNAs 3 and 5 as the viral E and N proteins is direct evidence for this assumption and demonstrates a correlation in relative abundance between viral RNAs and proteins. The presence in infected cells of smaller polypeptides related to the BEV N protein has been reported previously (Horzinek et al., 1985) . The 18K and 16K translation products can therefore be considered as premature termination products of N protein synthesis or its proteolytic fragments. This phenomenon resembles the degradation during immunoprecipitation of the MHV N protein translated in vitro, as reported for the strains A59 and JHM Siddell et al., 1980) . The identification of the 151K translation product of RNA 2 as virus-specific is not unambiguous. However, in tunicamycin-treated infected cells a protein of similar size is synthesized. This polypeptide has been identified as the unglycosylated form of the 200K intracellular precursor of the BEV peplomer proteins . For the moment the recognition of the 151K product by horse immune serum, though poorly, will have to suffice as evidence. Identification of this product may have been hampered by the low amount of RNA 2 in translation lysates and/or poor antigenicity of the unglycosylated polypeptide.
The appearance of multiple subgenomic RNAs in infected cells is not unusual for positivestranded RNA viruses. Nested sets of viral mRNAs, with 3' coterminal ends and expression of only the Y-terminal non-overlapping region, have been identified in cells infected with various coronaviruses (for a review, see Siddell et al., 1982) . In the togavirus family, equine arteritis virus also produces a 3' nested set (W. J. M. Spaan, unpublished data); the alphaviruses synthesize RNA of genome size plus one subgenomic mRNA, which again represents the 3'-terminal part of the genome (for a review, see Strauss & Strauss, 1983) . Several positive-stranded plant viruses have also been reported to produce subgenomic mRNAs during their multiplication (Goelet & Karn, 1982; Joshi & Haenni, 1984) . It will be interesting to see whether the BEV RNAs contain common sequences and in which way the subgenomic species are generated. The sizes of the translation products of RNAs 2, 3 and 5 are in good agreement with the theoretical non-overlapping coding capacities of a 3' coterminal nested set (26K, 23K and 178K, respectively) .
A number of similarities and differences between toroviruses and coronaviruses have been described. They resemble each other in having peplomer-bearing envelopes, a positive-stranded RNA genome of comparable size and multiple subgenomic mRNAs; however, the details of virion morphology, morphopoiesis and protein composition, as well as the sensitivity to AMD, discriminate these two families of viruses. At the molecular level, the sizes of the nucleocapsid RNAs and their translation products are different for toroviruses and coronaviruses. An 0.8 kb RNA encodes the 19K BEV N protein, whereas the nucleocapsid protein of coronaviruses has a characteristic size of 45K to 55K and is translated from a much larger RNA species (e.g. 1.8 kb for MHV A59). To study the replication strategy and genome organization, the molecular cloning of BEV RNA is in progress in our laboratory.
